Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Breastfeeding linked to reduced cardiovascular disease risk in mothers

Women who breastfed were less likely to develop heart disease or a stroke, or die from cardiovascular disease than women who did not breastfeed, according to a meta-analysis published today in a pregnancy spotlight issue of the Journal of the American Heart Association (JAHA), an open access, peer-reviewed journal of the American Heart Association.

11 Jan 2022

Human iPSC-derived fallopian tube organoids reveal the origins of common ovarian cancer

Stem cell scientists have revealed the origins of a common ovarian cancer by modeling fallopian tube tissues, allowing them to characterize how a genetic mutation puts women at high risk for this cancer.

29 Dec 2021

A class of FDA-approved drugs can effectively stop aggressive uterine cancer

A team of scientists led by the University of Michigan Health Rogel Cancer Center has found that a class of U.S. Food and Drug Administration-approved drugs can effectively stop a highly aggressive type of uterine cancer in its tracks, paving a quick path toward new treatment strategies for a deadly cancer with limited therapeutic options.

17 Dec 2021

Chemicals from certain personal care products may impact maternal hormone levels during pregnancy

Use of certain personal care products during pregnancy may impact maternal hormone levels, according to a new Rutgers study.

11 Dec 2021

Bilateral salpingo-oophorectomy may have risks for younger women, but safe for post-menopausal patients

A study of over 200,500 women who had a hysterectomy for non-cancerous reasons found an increased risk of death in women under 50 years of age when the ovaries and fallopian tubes were also removed during the surgery. The same association was not found in women over 50.

9 Dec 2021

Cancer registry offers a better understanding of ovarian granulosa cell tumors

Examination of Japanese cases of gynecological cancer offers a better understanding of the profile of a rare ovarian tumor and could change treatment guidelines.

4 Dec 2021

Study identifies two genes that play key role in protecting ovarian cancer from the immune system

Immunotherapies have shown striking clinical benefit in the treatment of many cancers, especially when used in combination with chemotherapy.

30 Nov 2021

Imaging drug that illuminates ovarian cancer tissue when exposed to fluorescent light gets FDA approval

The U.S. Food and Drug Administration (FDA) today approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons to more easily find and more precisely remove the cancer.

30 Nov 2021

Red blood cell distribution width as a biomarker for COVID-19

A review highlights the prospects and challenges of RDW as a predictive biomarker for viral infections, with a special focus on COVID-19 and hepatitis.

22 Nov 2021

New test enables patient-specific monitoring and treatment for ovarian cancer

Around 870 cases of ovarian cancer are reported in Belgium every year. Most of these patients are treated with surgical interventions and/or chemotherapy.

18 Nov 2021

Study reveals how certain cells drive immunotherapy resistance in ovarian cancer mouse model

Immune checkpoint inhibitors are a type of cancer treatment that help the immune system's T cells recognize and attack tumors. But these immunotherapy drugs aren't effective against all cancers.

12 Nov 2021

Study opens a window for new therapeutic approaches to ovarian cancer

A Ludwig Cancer Research study has uncovered a cellular interaction that is essential to the ability of the immune system's cytotoxic T lymphocytes to destroy ovarian tumors and shown that its engagement could help determine the efficacy of checkpoint blockade immunotherapy in a variety of cancers.

6 Nov 2021

Ensemble-based machine learning algorithms accurately predict anti-cancer drug responses

Today, machine learning, artificial intelligence, and algorithmic advancements made by research scientists and engineers are driving more targeted medical therapies through the power of prediction.

27 Oct 2021

Study reveals dual role of anti-cancer inhibitor

TG2, an enzyme known to help cancers spread more quickly, also plays a role in regulating T-cells, according to a Northwestern Medicine study published in the Journal for Immunotherapy of Cancer.

21 Oct 2021

Promising data from early clinical trials of new anticancer therapies presented at ESMO Congress 2021

Data from early clinical trials presented at the ESMO Congress 2021 suggest that new anticancer treatments are on the horizon, with a clear emphasis on precision medicine.

24 Sep 2021

Research pinpoints new therapeutic opportunity for ovarian clear cell carcinomas

Mutations in the ARID1A gene are present in more than 50% of ovarian clear cell carcinomas (OCCC), for which effective treatments are lacking. Scientists at The Wistar Institute discovered that loss of ARID1A function enhances a cellular stress response pathway that promotes survival of cancer cells, which become sensitive to pharmacological inhibition of this pathway. These findings were published online in Cancer Research, a journal of the American Association for Cancer Research, and point to a new therapeutic opportunity for this type of ovarian cancer for which new solutions are urgently needed.

22 Sep 2021

Systematic review focuses on women's health associated with menopausal hormone therapy

Treatment with estrogen in menopause is both good and bad for women's health. The picture is complex and the scientific evidence sometimes scanty or only moderately solid, a study shows. University of Gothenburg researchers took part.

20 Sep 2021

R37 MERIT Award supports innovative ovarian cancer research

One of the most impactful advancements during the past decade in treating ovarian cancer is the use of PARP inhibitors (short for poly adenosine diphosphate-ribose polymerase). PARP inhibitors are a type of cancer drug that blocks the PARP enzyme from helping to repair DNA damage in cancer cells.

18 Sep 2021

BAK/MCL1 complex in tumor cells can predict the sensitivity of chemotherapy drugs in ovarian cancer

A research team led by Prof. DAI Haiming from the Hefei Institutes of Physical Science (HFIPS) of the Chinese Academy of Sciences (CAS) recently announced the constitutive BAK/MCL1 complexes could predict chemotherapy drugs sensitivity of ovarian cancer. The result has been published on Cell death & disease.

16 Sep 2021

New center at UC San Diego to study the effects of antibiotics on mother’s milk and infant health

More than 70 percent of breastfeeding women take some form of medication, but 90 percent of those medications are not appropriately labeled for pregnant or lactating women.

10 Sep 2021

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Breastfeeding linked to reduced cardiovascular disease risk in mothers

Human iPSC-derived fallopian tube organoids reveal the origins of common ovarian cancer

A class of FDA-approved drugs can effectively stop aggressive uterine cancer

Chemicals from certain personal care products may impact maternal hormone levels during pregnancy

Bilateral salpingo-oophorectomy may have risks for younger women, but safe for post-menopausal patients

Cancer registry offers a better understanding of ovarian granulosa cell tumors

Study identifies two genes that play key role in protecting ovarian cancer from the immune system

Imaging drug that illuminates ovarian cancer tissue when exposed to fluorescent light gets FDA approval

Red blood cell distribution width as a biomarker for COVID-19

New test enables patient-specific monitoring and treatment for ovarian cancer

Study reveals how certain cells drive immunotherapy resistance in ovarian cancer mouse model

Study opens a window for new therapeutic approaches to ovarian cancer

Ensemble-based machine learning algorithms accurately predict anti-cancer drug responses

Study reveals dual role of anti-cancer inhibitor

Promising data from early clinical trials of new anticancer therapies presented at ESMO Congress 2021

Research pinpoints new therapeutic opportunity for ovarian clear cell carcinomas

Systematic review focuses on women's health associated with menopausal hormone therapy

R37 MERIT Award supports innovative ovarian cancer research

BAK/MCL1 complex in tumor cells can predict the sensitivity of chemotherapy drugs in ovarian cancer

New center at UC San Diego to study the effects of antibiotics on mother’s milk and infant health

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in